Product image of Midazolam Accord (Midazolam) supplied by GNH India

Midazolam Accord

Active Ingredient:
Midazolam
Origin:
EU

Midazolam Accord (Midazolam)

Midazolam, the active ingredient in Midazolam Accord, is a benzodiazepine presented as a sterile injectable solution for intramuscular and intravenous use. It provides rapid sedation, anxiolysis and anticonvulsant effects for patients undergoing procedures, surgery or acute seizures.\n\nGNH India supplies Midazolam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Midazolam is a benzodiazepine that acts on the central nervous system to produce sedation, anxiolysis and seizure control.\n\nProcedural sedation: enables safe, short‑term sedation for diagnostic or therapeutic procedures.\nPre‑anesthetic medication: reduces anxiety and facilitates induction of anesthesia.\nAcute seizure control: terminates ongoing seizures when rapid intravenous administration is required.\nSevere anxiety: provides short‑term relief of intense anxiety in acute settings.

How It Works

  • Midazolam enhances the activity of the gamma‑aminobutyric acid type A (GABA‑A) receptor complex. By binding to a specific site on the receptor, it increases the frequency of chloride channel opening, leading to greater chloride influx, hyperpolarization of neuronal membranes and reduced neuronal excitability, resulting in central nervous system depression.

Side Effects

  • Midazolam may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Drowsiness or somnolence\n- Dizziness or light‑headedness\n- Fatigue or weakness\n- Anterograde amnesia\n- Mild hypotension\n- Transient respiratory depression\n\nSerious or Rare Side Effects:\n- Severe respiratory depression or apnea\n- Marked hypotension or cardiovascular collapse\n- Paradoxical reactions such as agitation or aggression\n- Anaphylactic or severe allergic reactions\n- Cardiac arrhythmias or arrest\n- Withdrawal seizures on abrupt discontinuation

Precautions & Warnings

  • When using Midazolam, clinicians should observe specific safety measures.\n\nAssess respiratory function: monitor oxygen saturation and ventilation.\nMonitor cardiovascular status: watch for hypotension and arrhythmias.\nUse caution in elderly: lower doses may be required due to increased sensitivity.\nAvoid abrupt discontinuation: taper to prevent withdrawal seizures.\nAdjust dose in hepatic impairment: reduced clearance may increase effects.\nStore at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

  • Midazolam interacts with several drug classes that can modify its sedative effect.\n\nMajor Interactions (Avoid):\n- Opioids (e.g., fentanyl, morphine): additive respiratory depression.\n- Other CNS depressants (e.g., barbiturates, alcohol): profound sedation.\n- Anticholinesterases (e.g., neostigmine): may reduce sedative effect.\n- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase plasma levels.\n\nModerate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (e.g., fluoxetine): may enhance sedation.\n- Antihypertensives (e.g., beta‑blockers): additive hypotensive effect.\n- Antiepileptic drugs (e.g., carbamazepine): may decrease efficacy.\n- Oral contraceptives: potential alteration of hormone levels.

Frequently Asked Questions

Midazolam Accord is used for procedural sedation, pre‑anesthetic medication, acute seizure control and short‑term relief of severe anxiety. It provides rapid onset of sedation and anticonvulsant effects when administered intravenously or intramuscularly.

Midazolam binds to a specific site on the GABA‑A receptor, enhancing the inhibitory action of GABA. This increases chloride ion influx, hyperpolarizes neuronal membranes, and reduces neuronal firing, leading to sedation, anxiolysis and seizure suppression.

The dose of Midazolam Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition and route of administration. Healthcare professionals adjust the amount to achieve the desired level of sedation or seizure control.

The safety of Midazolam in pregnancy and lactation is not well established. It is classified as a pregnancy category unknown, and clinicians should weigh potential benefits against risks. Use is generally avoided unless clearly indicated.

To order Midazolam Accord, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Midazolam is a short‑acting benzodiazepine, offering rapid onset and relatively brief duration compared with longer‑acting agents like diazepam. Its potency and ease of titration make it preferred for procedural sedation, whereas other classes such as propofol provide deeper anesthesia but require more intensive monitoring.

Midazolam Accord should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and sterility.

Midazolam Accord is supplied as a sterile injectable solution and can be given intravenously or intramuscularly by a qualified healthcare professional. The route and rate of administration are selected according to the clinical indication and patient response.

The most serious risks include severe respiratory depression, profound hypotension, paradoxical reactions such as agitation, and rare anaphylactic responses. Continuous monitoring of respiratory and cardiovascular status is essential during and after administration.

Midazolam should be avoided in patients with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, or those who are pregnant without a clear medical indication. Caution is also advised for individuals with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT